Treatment of Neurogenic Bladder Dysfunction in Infants and Children with Neurospinal Dysraphism with Clean Intermittent (Self)Catheterisation and Optimized Intravesical Oxybutynin Hydrochloride Therapy

European Journal of Pediatric Surgery

Volumn 5, Issue , 1995, Pages 31-34

  Buyse, G ^a   Verpoorten, Carla ^a   Vereecken, R ^a   Casaer, P ^a  

^a Department of Radiology and Cardiology   (Germany)

Author keywords

Intravesical therapy; Neurogenic bladder dysfunction; Oxybutynin

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN;

ADOLESCENT; BLADDER CATHETERIZATION; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DETRUSOR DYSSYNERGIA; DRUG ADMINISTRATION; DYSRAPHISM; HUMAN; INFANT; NEUROGENIC BLADDER; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; SELF CARE;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; MALE; MANDELIC ACIDS; SPINAL DYSRAPHISM; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY CATHETERIZATION;

EID: 0029572395     PISSN: 09397248     EISSN: 1439359X     Source Type: Journal    
DOI: 10.1055/s-2008-1066260     Document Type: Article

References (17)

1. Baskin LS, Kogan BA, Benard F: Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 66 (1990) 532-534
2. Bauer SB: Neurogenic bladder dysfunction. Pediatr Clin North Am 34 (1987) (532-534)
3. Bauer SB: Joseph DB: Management of the obstructed urinary tract associated with neurogenic bladder dysfunction. Urol Clin North Am 17 (1990) 395-406
4. Bonney WW, Robinson RA, Theobald RJ: Topical effect oF intravesical oxybutynin. J Urol 150 (1993) 1522-1525
5. Borzyskowski M: The conservative management of neuropathic vesicourethral dysfunction. In: Neuropathic Bladders in Childhood Clin Dev Med 111 (1990) 27-36
6. Brendler CB, Radebaugh LC, Mohler JL: Topical oxybutynin chloride for relaxation of dysfunctional bladders J Urol 141 (1989) 1350-1352
7. Connor JP, Betrus G, Fleming P, Perlmutter AD, Reitelman C; Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 151 (1994) 1045-1047
8. Fernandes ET, Reinberg Y, Vernier R, Gonzales R: Neurogenic bladder dysfunction in children: review of pathophysiology and current management. J Pcdiatr 124 (1994) 1-7
9. Goll JD van: Spina Bifida and Neurogenic Bladder Dysfunction. A Urodynamic Study. Impress, Utrecht 1986
10. Greenfield SP, Fera M: The use of intravesical oxybutynin chloride in children with neurogenic bladders. J Urol 146 (1991) 532-534
11. Hernandez RD, Hurwitz RS, Foote JE, Zimmern PE, Leach GE: Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol 152 (1994) 1582-1585
12. Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB: The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J Urol 151 (1994) 944-945
13. Lorber J: Spina bifida cystica. Results of treatment of 270 consecutive cases with criteria for selection for the future. Arch Dis Child 47 (1972) 854
14. Madersbacher H, Jilg G: Control of detrusor hyperreflexia by the intravesical instillation of oxybutynin hydrochloride. Paraplegia 29 (1991) 84-90
15. Massad CA, Kogan BA, Trigo-Rocha FE: The pharmacokinetics intravesical and oral oxybutynin hydrochloride. J Urol 148 (1992) 595-597
16. Mizunaga M, Miyata M, Kaneko S, Yachiku S, Chiba K: Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder Paraplegia 32 (1994) 25-29
17. Singh G, Thomas DG: Intravesical oxybutynin in patients with posterior rhizotomies and sacral root stimulators. Neurourol Urodvn 14 (1995) 65-71